Elixinol Wellness Full Year 2024 Earnings: AU$0.011 loss per share (vs AU$0.13 loss in FY 2023)
Elixinol Wellness (ASX:EXL) Full Year 2024 Results
Key Financial Results
- Revenue: AU$15.3m (up 85% from FY 2023).
- Net loss: AU$1.72m (loss narrowed by 77% from FY 2023).
- AU$0.011 loss per share (improved from AU$0.13 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Elixinol Wellness shares are down 11% from a week ago.
Risk Analysis
You should learn about the 4 warning signs we've spotted with Elixinol Wellness.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10